Crystallization and preliminary X-ray diffraction studies of human cytochrome P450 reductase

J Struct Biol. 1996 Mar-Apr;116(2):320-5. doi: 10.1006/jsbi.1996.0048.

Abstract

The two functional domains of a cloned human fibroblast NADPH-cytochrome P450 reductase have been expressed in Escherichia coli and purified on the milligram scale for crystallization studies. One domain contains the cofactor FMN-binding site and the other contains the binding sites for cofactor FAD and substrate NADPH. Crystals of both domains have been obtained by the microbatch method. The crystals of the FMN domain belong to the monoclinic space group P21, with unit cell dimensions of a = 39.3 A, b = 51.5 A, c = 47.8 A, and beta = 105.7 degrees and have one molecule in the asymmetric unit. Diffraction data up to 2.3 A were collected with a merging residual on intensity of 9.3%. The crystals of the FAD/NADPH domain belong to the ortho-rhombic space group P212121 with unit cell dimensions of a = 55.9 A, b = 58.6 A, c = 131.1 A and have one molecule in the asymmetric unit. Diffraction data up to 2.6 A were collected with a merging residual on intensity of 8.0%.

MeSH terms

  • Amino Acid Sequence
  • Binding Sites
  • Crystallography, X-Ray
  • DNA, Complementary / genetics
  • Fibroblasts / enzymology
  • Flavin Mononucleotide / metabolism
  • Flavin-Adenine Dinucleotide / metabolism
  • Molecular Sequence Data
  • NADH, NADPH Oxidoreductases / chemistry*
  • NADH, NADPH Oxidoreductases / genetics
  • NADH, NADPH Oxidoreductases / isolation & purification
  • NADP / metabolism
  • NADPH-Ferrihemoprotein Reductase
  • Protein Binding
  • Recombinant Fusion Proteins / chemistry
  • Recombinant Fusion Proteins / isolation & purification

Substances

  • DNA, Complementary
  • Recombinant Fusion Proteins
  • Flavin-Adenine Dinucleotide
  • NADP
  • Flavin Mononucleotide
  • NADH, NADPH Oxidoreductases
  • NADPH-Ferrihemoprotein Reductase